Back to Top Skip to main content Skip to sub-navigation

COVID-19 Treatment

In December 2021, the FDA issued an Emergency Use Authorization (EUA) for two oral antivirals for the treatment of COVID-19: Paxlovid and Molnupiravir. TRICARE now covers these treatments at military pharmacies, in-network pharmacies, and non-network pharmacies, and beneficiaries will have a $0 charge.

Beginning Jan. 14, 2022, TRICARE’s coverage will expand to include the Paxlovid and Molnupiravir oral antivirals to military pharmacies, in-network pharmacies, as well as at out-of-network pharmacies. Oral antivirals dispensed at pharmacies are at no cost to beneficiaries with an order from an authorized provider. Beneficiaries are encouraged to contact their pharmacy of choice to ensure that there is an adequate supply of the antiviral treatment.

Beneficiaries should be aware that with each treatment, there is a limited quantity restriction. With either antiviral medication, the beneficiaries are limited to one course of treatment per 180 days.

Key Messages

Expand to see key messages.

Messages for Communicators

Talking Points

Expand for a list of talking points.

Talking Points for Communicators

Graphics

Screensaver

 COVID-19 Test to Treat Available HEre COVID-19 Test to Treat Available Here

If your military hospital or clinic offers these antiviral treatments as part of the COVID-19 Test to Treat Initiative, use these graphics to promote your services to your beneficiaries.

In December 2021, the FDA issued an Emergency Use Authorization (EUA) for two oral antivirals for the treatment of COVID-19: Paxlovid and Molnupiravir. TRICARE now covers these treatments at military pharmacies, in-network pharmacies, and non-network pharmacies, and beneficiaries will have a $0 charge.

Social Media Graphic

In December 2021, the FDA issued an Emergency Use Authorization (EUA) for two oral antivirals for the treatment of COVID-19: Paxlovid and Molnupiravir. TRICARE now covers these treatments at military pharmacies, in-network pharmacies, and non-network pharmacies, and beneficiaries will have a $0 charge.

You also may be interested in...

COVID-19 Testing and Treatment Main Graphic

Infographic
4/21/2022
COVID-19 Testing and Treatment Main Graphic

If your military hospital or clinic offers these antiviral treatments as part of the COVID-19 Test to Treat Initiative, use these graphics to promote your services to your beneficiaries.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Treatment

COVID-19 Testing and Treatment Graphic 2

Infographic
4/21/2022
COVID-19 Testing and Treatment Graphic 2

If your military hospital or clinic offers these antiviral treatments as part of the COVID-19 Test to Treat Initiative, use these graphics to promote your services to your beneficiaries.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Treatment

COVID-19 Oral Antiviral Social Post

Infographic
2/23/2022
COVID-19 Oral Antiviral Social Post

In December 2021, the FDA issued an Emergency Use Authorization (EUA) for two oral antivirals for the treatment of COVID-19: Paxlovid and Molnupiravir. TRICARE now covers these treatments at military pharmacies, in-network pharmacies, and non-network pharmacies, and beneficiaries will have a $0 charge. Share this image on your social media platforms to spread the news.

Recommended Content:

COVID-19 Treatment

COVID-19 Oral Antivirals Screensaver

Infographic
2/23/2022
COVID-19 Oral Antivirals Screensaver

In December 2021, the FDA issued an Emergency Use Authorization (EUA) for two oral antivirals for the treatment of COVID-19: Paxlovid and Molnupiravir. TRICARE now covers these treatments at military pharmacies, in-network pharmacies, and non-network pharmacies, and beneficiaries will have a $0 charge. Use this screensaver at your facility to promote the information.

Recommended Content:

COVID-19 Treatment
Showing results 1 - 4 Page 1 of 1
Last Updated: April 21, 2022

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.